LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Список акций・Stryker Corp

Stryker Corp

Закрыт

СекторЗдравоохранение

300.74 1.73

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

295.06

Макс.

305.82

Ключевые показатели
By Trading Economics
Доход	-104M 745M
Продажи	-1.2B 6B
P/E Средняя по отрасли	34.62 49.888
Прибыль на акцию	2.6
Дивидендная доходность	1.13
Рентабельность продаж	12.375
Сотрудники	56,000
EBITDA	-478M 1.2B

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+31.53% upside

Дивиденды
By Dow Jones
Дивидендная доходность Средняя по отрасли	1.13% 2.38%
Следующий отчет о доходах	30 июл. 2026 г.
Дата следующей выплаты дивидендов	31 июл. 2026 г.
Следующая эксдивидендная дата	30 июн. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-11B 115B
Предыдущая цена открытия	299.01
Предыдущая цена закрытия	300.74

Новостные настроения

By Acuity

55%

45%

274 / 344 Рейтинг в Healthcare

Stryker Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

30 апр. 2026 г., 20:41 UTC

Отчет

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12 мар. 2026 г., 21:42 UTC

Главные новостные события

Stryker Says Cyberattack Disruption Is Continuing

11 мар. 2026 г., 19:18 UTC

Главные движущие силы рынка

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29 янв. 2026 г., 22:05 UTC

Отчет

Stryker Logs Higher 4Q Profit On Sales Gains

30 окт. 2025 г., 20:36 UTC

Отчет

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30 апр. 2026 г., 20:06 UTC

Отчет

Stryker 1Q Organic Net Sales Up 2.4%

30 апр. 2026 г., 20:06 UTC

Отчет

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q Adj EPS $2.60 >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q EPS $1.93 >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q Net $745M >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q Sales $6.02B >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q Net $745M >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q Adj EPS $2.60 >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q EPS $1.93 >SYK

30 апр. 2026 г., 20:05 UTC

Отчет

Stryker 1Q Sales $6B >SYK

9 апр. 2026 г., 20:55 UTC

Отчет

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 апр. 2026 г., 20:55 UTC

Отчет

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 апр. 2026 г., 20:55 UTC

Отчет

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16 мар. 2026 г., 00:00 UTC

Главные новостные события

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30 янв. 2026 г., 17:03 UTC

Обсуждения рынка

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 янв. 2026 г., 21:07 UTC

Отчет

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 янв. 2026 г., 21:05 UTC

Отчет

Stryker 4Q Adj EPS $4.47 >SYK

5 нояб. 2025 г., 19:38 UTC

Отчет

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 нояб. 2025 г., 17:00 UTC

Отчет

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 окт. 2025 г., 20:21 UTC

Отчет

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 окт. 2025 г., 20:05 UTC

Отчет

Stryker 3Q Adj EPS $3.19 >SYK

30 окт. 2025 г., 20:05 UTC

Отчет

Stryker 3Q EPS $2.22 >SYK

30 окт. 2025 г., 20:05 UTC

Отчет

Stryker 3Q Sales $6.1B >SYK

30 окт. 2025 г., 20:05 UTC

Отчет

Stryker 3Q Net $859M >SYK

Сравнение c конкурентами

Изменение цены

Stryker Corp Прогноз

Целевая цена

By TipRanks

31.53% рост

Прогноз на 12 месяцев

Средняя 388 USD 31.53%

Максимум 450 USD

Минимум 315 USD

Основано на мнении 22 аналитиков Wall Street, спрогнозировавших целевые цены для Stryker Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

22 ratings

Покупка

Удержание

Продажа

Основано на мнении 22 аналитиков, присваивавших рейтинги акциям Stryker Corp – Данные за последние 3 месяца.

Настроения

By Acuity

274 / 344Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.